Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Tegsedi for the Treatment of Polyneuropathy of hATTR Amyloidosis

Tegsedi™ (inotersen) is a RNA-targeting therapeutic indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis. Images courtesy of Akcea Therapeutics, Ionis Pharmaceuticals.

  • Tegsedi
  • Tegsedi
  • Tegsedi

Go Top